ESPEN Guidelines on Enteral Nutrition: Cardiology and Pulmonology

Clinical Nutrition

Volumn 25, Issue 2, 2006, Pages 311-318

  Anker, S D ^a   John, M ^a   Pedersen, P U ^b   Raguso, C ^c   Cicoira, M ^d   Dardai, E ^e   Laviano, A ^f   Ponikowski, P ^g   Schols, A M W J ^h   Becker, H F ⁱ   Bohm M ⁱ   Brunkhorst, F M ⁱ   Vogelmeier, C ⁱ  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Rigshospitalet   (Denmark)

^c Hôpital Cantonal   (Switzerland)

^d UNIVERSITY OF VERONA   (Italy)

^e Saint Stephen Hospital   (Hungary)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g MILITARY HOSPITAL   (Poland)

^h MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ NONE

Author keywords

Clinical practice; Enteral nutrition (EN); Evidence based; Guideline; Oral nutritional supplements; Tube feeding

Indexed keywords

ARTICLE; CACHEXIA; CARDIOLOGY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSENSUS DEVELOPMENT; DIET SUPPLEMENTATION; DYSPNEA; ENTERIC FEEDING; EUROPE; EVIDENCE BASED MEDICINE; EXERCISE; FEEDING BEHAVIOR; FOOD INTAKE; HEART FAILURE; HUMAN; INTERNET; MEDICAL EXPERT; MEDICAL LITERATURE; MEDICAL SOCIETY; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PATIENT COMPLIANCE; PHYSICAL CAPACITY; POSTPRANDIAL STATE; PRACTICE GUIDELINE; PROGNOSIS; PULMONOLOGY; SATIETY; SURVIVAL RATE; TUBE FEEDING; WEIGHT REDUCTION;

CARDIOLOGY; ENTERAL NUTRITION; EUROPE; HEART FAILURE; HEART FAILURE, CONGESTIVE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PULMONARY DISEASE (SPECIALTY); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE;

EID: 33744796840     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2006.01.017     Document Type: Article

References (69)

1. Cowie M.R., Mosterd A.A., Wood D.A., et al. The epidemiology of heart failure. Eur Heart J 18 (1997) 208-225
2. Berry C., and Clark A.L. Catabolism in chronic heart failure. Eur Heart J 21 (2000) 521-532
3. Mancini D.M., Walter G., Reichek N., et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85 (1992) 1364-1373
4. Anker S.D., and Coats A.J.S. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest 115 (1999) 836-847
5. Anker S.D., Negassa A., Coats A.J.S., et al. Prognostic importance of weight loss in chronic heart and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361 (2003) 1077-1083
6. Anker S.D., Ponikowski P.P., Clark A.L., et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 20 (1999) 683-693
7. Anker S.D., Clark A.L., Teixeira M.M., Helleerll P.G., and Coats A.J.S. Loss of bone mineral in patients with cachexia due to chronic heart failure. Am J Cardiol 83 (1999) 612-615
8. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor of survival in chronic heart failure. Lancet 349 (1997) 1050-1053
9. Poehlmann E.T., Scheffers J., Gottlieb S.S., Fisher M.L., and Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med 121 (1994) 860-862
10. Toth M.J., Gottlieb S.S., Goran M.I., Fisher M.L., and Poehlman E.T. Daily energy expenditure in free-living heart failure patients. Am J Physiol 272 (1997) 469-475
11. Anker S.D., Chua T.P., Swan J.W., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure: the importance for cardiac cachexia. Circulation 96 (1997) 526-534
12. Anker S.D., Clark A.L., Kemp M., et al. Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. J Am Coll Cardiol 30 (1997) 997-1001
13. Anker S.D., Volterrani M., Pflaum C.-D., et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol 38 (2001) 443-452
14. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
15. Rauchhaus M., Doehner W., Francis D.P., et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (2000) 3060-3067
16. King D., Smith M.L., and Lye M. Gastro-intestinal protein loss in elderly patients with cardiac cachexia. Age Ageing 25 (1996) 221-223
17. King D., Smith M.L., Chapman T.J., Stockdale H.R., and Lye M. Fat malabsorption in elderly patients with cardiac cachexia. Age Ageing 25 (1996) 144-149
18. Aquilani R., Opasich C., Verri M., et al. Is nutritional intake adequate in chronic heart failure patients?. J Am Coll Cardiol 42 (2003) 1218-1223
19. Heymsfield S.B., and Casper K. Congestive heart failure: clinical management by use of continuous nasoenteric feeding. Am J Clin Nutr 50 (1989) 539-544
20. Freeman L.M., and Roubenoff R. The nutrition implications of cardiac cachexia. Nutr Rev 52 (1994) 340-347
21. Mustafa I., and Leverve X. Metabolic and nutritional disorders in cardiac cachexia. Nutrition 17 (2001) 756-760
22. Otaki M. Surgical treatment of patients with cardiac cachexia. An analysis of factors affecting operative mortality. Chest 105 (1994) 1347-1351
23. Paccagnella A., Calo M.A., Caenaro G., et al. Cardiac cachexia: preoperative and postoperative nutrition management. JPEN J Parenter Enteral Nutr 18 (1994) 409-416
24. Herndon D.N., Hart D.W., Wolf S.E., Chinkes D.L., and Wolfe R.R. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 345 (2001) 1223-1229
25. Arutiunov G.P., Kostiukevich O.I., Rylova N.V., Voevodina Niu, and Korsunskaja M.I. Effect of enteral feeding on exercise tolerance and clincal picture in patients with NYHA class III-IV chronic heart failure. Kardiologiia 43 5 (2003) 52-55
26. Schols A.M., Soeters P.B., Dingemans A.M., Mostert R., Frantzen P.J., and Wouters E.F. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147 (1993) 1151-1156
27. Vermeeren MA, Creutzberg EC, Schols AM, Postma DS, Pieters WR, Roldaan AC, Wouters EF; on behalf of the COSMIC Study Group. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006 January 10 [Epub. ahead of print].
28. Cano N., Roth H., Court-Ortune I., et al. Clinical Research Group of the Societe Francophone de Nutrition Enteral et Parenteral. Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation. Eur Resp J 20 (2002) 30-37
29. Bolton C.E., Ionescu A.A., Edwards P.H., Faulkner T.A., Edwards S.M., and Shale D.J. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 12 (2004) 1286-1293
30. Gulsvik A. The global burden and impact of chronic obstructive pulmonary disease worldwide. Monaldi Arch Chest Dis 56 (2001) 261-264
31. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 117 2 Suppl. (2000) 1S-4S
32. Di Francia M., Barbier D., Mege J., Orehek J., et al. Tumor necrosis factor-alpha and weight loss in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 150 (1994) 1453-1455
33. Congleton J. The pulmonary cachexia syndrome: aspects of energy balance. Proc Nutr Soc 58 (1999) 321-328
34. Farber M.O., and Mannix E.T. Tissue wasting in patients with chronic obstructive pulmonary disease. Neurol Clin 18 (2000) 245-262
35. Schols A.M., and Wouters E.F. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease. Clin Chest Med 21 (2000) 753-762
36. Thorsdottir I., Gunnarsdottir I., and Eriksen B. Screening method evaluated by nutritional status measurements can be used to detect malnourishment in chronic obstructive pulmonary disease. J Am Diet Assoc 101 (2001) 648-654
37. Schols A.M., Creutzberg E.C., Buurman W.A., Campfield L.A., Saris W.H., and Wouters E.F. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1220-1226
38. Takabatake N., Nakamura H., Minamihaba O., et al. A novel pathophysiologic phenomenon in cachexic patients with chronic obstructive pulmonary disease: the relationship between the circadian rhythm of circulating leptin and the very low-frequency component of heart rate variability. Am J Respir Crit Care Med 163 (2001) 1289-1290
39. Raguso C.A., Guinot S.L., Janssens J.P., Kayser B., and Pichard C. Chronic hypoxia: common traits between chronic obstructive pulmonary disease and altitude. Curr Opin Clin Nutr Metab Care 7 (2004) 411-417
40. Baarends E.M., Schols A.M., Pannemans D.L., Westerterp K.R., and Wouters E.F. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 155 (1997) 549-554
41. Schiffelers S.L., Blaak E.E., Baarends E.M., et al. ß-Adrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease. Am J Physiol Endocrinol Metab 280 (2001) E357-E364
42. Saudny-Unterberger H., Martin J.G., and Gray-Donald K. Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156 3 Part 1 (1997) 794-799
43. Koerts-de Lang E., Schols A.M., Rooyackers O.E., Gayan-Ramirez G., Decramer M., and Wouters E.F. Different effects of corticosteroid-induced muscle wasting compared with undernutrition on rat diaphragm energy metabolism. Eur J Appl Physiol 82 (2000) 493-498
44. Wilson D.O., Rogers R.M., Wright E.C., and Anthonisen N.R. Body weight in chronic obstructive pulmonary disease: the National Institutes of Health Intermittent Positive Pressure Breathing Trial. Am Rev Respir Dis 139 (1989) 1435-1438
45. Schols A.M. Nutrition in chronic obstructive pulmonary disease. Curr Opin Pulm Med 6 (2000) 110-115
46. Schols A.M., Slangen J., Volovics L., and Wouiters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1791-1797
47. Prescott E., Almdal T., Mikkelsen K.L., Tofteng C.L., Vestbo J., and Lange P. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 20 (2002) 539-544
48. Marquis K., Debigare R., Lacasse Y., et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 809-813
49. Schols A.M.W.J., Broekhuizen R., Weling-Scheepers C.A.P., and Wouters E.F.M. Body composition and mortality in COPD. AJCN 82 1 (2005) 53-59
50. Vestbo J., Prescott E., Almdal T., et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the copenhagen city heart study. Am J Respir Crit Care Med 173 1 (2006) 79-83
51. Slinde F, Gronberg A, Engstrom CP, Rossander-Hulthen L, Larsson S. Body composition by bioelectrical impedance predicts mortality in chronic obstructive pulmonary disease patients. Respir Med. 2005;99(8):1004-9 [Epub. 2005 April 12].
52. Engelen M.P., Schols A.M., Baken W.C., Wesseling G.J., and Wouters E.F. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 7 (1994) 1793-1797
53. Baarends E.M., Schols A.M., Mostert R., and Wouters E.F. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 10 (1997) 2807-2813
54. Mostert R., Goris A., Weling-Scheepers C., Wouters F.E.M., and Schols A.M.W.J. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 9 (2000) 859-867
55. Ferreira IM, Brooks D, Lacasse Y, Goldstein RS, White J. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002;1:CD000998.
56. Goris A.H.C., Vermeeren M.A.P., Wouters E.F.M., Schols A.M.W.J., and Westerterp K.R. Energy balance in depleted ambulatory patients with chronic obstructive pulmonary disease: the effect of physical activity and oral nutritional supplementation. Br J Nutr 89 (2003) 725-729
57. Creutzberg E.C., Schols A.M.W.J., Weling-Scheepers C.A.P.M., Buurman W.A., and Wouters E.F.M. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 (2000) 745-752
58. Broekhuizen R., Creutzberg E.C., Weling-Scheepers C.A., Wouters E.F.M., and Schols A.M.W.J. Optimizing oral nutritional drink supplementation in patients with chronic obstructive pulmonary disease. BJN 93 6 (2005) 965-971
59. Schols A.M., Soeters P.B., Mostert R., Pluymers R.J., and Wouters E.F. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 152 (1995) 1268-1274
60. Creutzberg E.C., Wouters E.F.M., Mostert R., Weling-Scheepers C.A.P.M., and Schols A.M.W.J. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 19 (2003) 120-127
61. Steiner M.C., Barton R.L., Singh S.J., and Morgan M.D. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 58 9 (2003) 745-751
62. Slinde F., Gronberg A.M., Engstrom C.R., Rossander-Hulthen L., and Larsson S. Individual dietary intervention in patients with COPD during multidisciplinary rehabilitation. Respir Med 96 5 (2002) 330-336
63. Vermeeren M.A.P., Wouters E.F.M., Nelissen L.H., van Lier A., Hofman Z., and Schols A.M. Acute effects of different nutritional supplements on symptoms and functional capacity in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 73 (2001) 295-301
64. Efthimiou J., Mounsey P.J., Benson D.N., Madgwick R., Coles S.J., and Benson M.K. Effect of carbohydrate rich versus fat rich loads on gas exchange and walking performance in patients with chronic obstructive lung disease. Thorax 47 6 (1992) 451-456
65. Brown S.E., Nagendran R.C., McHugh J.W., Stansbury D.W., Fischer C.E., and Light RW. Effects of a large carbohydrate load on walking performance in chronic air-flow obstruction. Am Rev Respir Dis 132 5 (1985) 960-962
66. Frankfort J.D., Fischer C.E., Stansbury D.W., McArthur D.L., Brown S.E., and Light R.W. Effects of high- and low-carbohydrate meals on maximum exercise performance in chronic airflow obstruction. Chest 100 3 (1991) 792-795
67. Akrabawi S.S., Mobarhan S., Stoltz R.R., and Ferguson P.W. Gastric emptying, pulmonary function, gas exchange, and respiratory quotient after feeding a moderate versus high fat enteral formula meal in chronic obstructive pulmonary disease patients. Nutrition 12 4 (1996) 260-265
68. Schütz T., Herbst B., and Koller M. Methodology for the development of the ESPEN Guidelines on Enteral Nutrition. Clin Nutr 25 2 (2006) 203-209
69. Lochs H., Allison S.P., Meier R., Pirlich M., Kondrup J., Schneider St., van der Berghe G., and Pichard C. Introductory to the ESPEN Guidelines on Enteral Nutrition: Terminology, Definitions and General Topics. Clin Nutr 25 2 (2006) 180-186